Electrophoretic and serologic characterization of 56 kDa antigen (M56) with autologous serum derived from a chondrosarcoma patient: A shared antigen of immunoresponses in cancer and autoimmune diseases

Kazuo Fujiwara, Heiichiro Udono, Toshiyuki Kunisada, Akira Kawai, Hajime Inoue, Masaharu Takigawa, Masayoshi Namba, Eiichi Nakayama

Research output: Contribution to journalArticle

1 Citation (Scopus)


We investigated whether antibodies specific to autologous cancer cells are produced in the peripheral blood of patients with chondrosarcoma. There have been few reports on the investigation of the immune responses, such as autologous antibody production, to chondrosarcoma. Here, tumor-associated antigens were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and detected by immunoenzymatic amplification. A 56 kDa molecule (M56) was detected in the serum from patients' peripheral blood. M56 is ubiquitously expressed in various kinds of tissue-derived cells. However, the molecule seemed to be retained mostly in the cytosolic compartment of lymphoid cells, while it was expressed on the cell surface of nonlymphoid cancer cells. Furthermore, the antibodies reactive to the 56 kDa molecule were frequently observed in sera derived from patients with other cancers and autoimmune diseases as compared to the sera from healthy control donors, suggesting that M56 is a common target molecule of immune responses in patients with various cancers and autoimmune diseases.

Original languageEnglish
Pages (from-to)3335-3342
Number of pages8
Issue number17
Publication statusPublished - 1999



  • Autoantibody
  • Autoimmune diseases
  • Chondrosarcoma
  • Shared antigen
  • Western blotting

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this